Biologics in China: Fourth Quarter Results Snapshot



[ad_1]

BEIJING (AP) _ China Biologic Products Inc. (CBPO) on Monday reported fourth quarter net income of $ 23.7 million.

The Beijing-based company said it had net income of 59 cents per share. Earnings, adjusted for stock option expense and depreciation expense, were 91 cents per share.

The biopharmaceutical company recorded revenues of $ 112.1 million during the period.

For the year, the company reported profit of $ 152.3 million, or $ 3.82 per share. Revenue was $ 524.4 million.

China Biologic Products shares have risen slightly since the start of the year. In the closing minutes of trading on Monday, shares hit $ 118.33, an increase of almost 9% in the past 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks inventory report on CBPO ​​at https://www.zacks.com/ap/CBPO

[ad_2]
Source link